Robert Jenq

Rob Jenq currently serves as a Professor and Director of the Microbiome Program at City of Hope, beginning in September 2024. Concurrently, Rob Jenq holds positions as a Scientific Advisor for Postbiotics Plus and has been a member of the Scientific Advisory Board for MaaT Pharma and Seres Therapeutics since 2020 and 2016, respectively. Prior experience includes serving as Associate Professor and Deputy Chair in the Department of Genomic Medicine at MD Anderson Cancer Center until September 2024. Rob Jenq's career also features advisory roles with several organizations, including Prolacta Bioscience, Kaleido Biosciences, and LISCure Biosciences Inc. Educational credentials include a Medical Doctor degree from Oregon Health & Science University and an AB in Chemistry from Princeton University.